Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy

Abstract

Aims. It is not known whether the apparent normality of echocardiographic examination results, in subjects bearing a mutation for hypertrophic cardiomyopathy but without ultrasonic left ventricular hypertrophy, is due to incomplete phenotypic expression, or inaccurate echocardiographic criteria. The aim of this study was to search for echocardiographic abnormalities in these patients. Methods and Results. Echocardiography was performed in 100 subjects from two families with a mutation in the β-MHC (720) or My-BPC (714) genes. We compared genetically affected subjects with an apparently normal left ventricle (thickness < 13 mm) (20 patients), and non-affected first-degree relatives (61 normal subjects). (1) Patients had a thicker left ventricular wall (9.7 ± 1.4 vs 8.9 ± 1.4 mm, P = 0.03), a greater indexed mass (107 ± 18 vs 97 ± 17 g.m-2, P = 0.03), a larger left atrium (27 ± 9 vs 23 ± 10 mm3, P = 0.09) and lower wall stress (78 ± 11 vs 89 ± 15 103 dynes.cm-2, P = 0.002); these differences were highly significant after adjustment for height, age and systolic blood pressure either for wall thickness (P = 0.000003), mass (P = 0.005) or atrial volume (P = 0.001), and the ventricular systolic dimension appeared smaller (P = 0.01); (2) results remained significant (P < 0.01) when a lower cut-off value (≤ 11 mm) or only adults (≤ 18 years) were considered; (3) a subanalysis of Family 714 (13 patients, 25 normals matched for sex, age and height) showed the same trends. Conclusion. In familial hypertrophic cardiomyopathy, genetically affected subjects with an apparently normal heart by echocardiography show slight ultrasonic structural and functional left ventricular modifications, suggesting that the phenotype of the disease is a continuous spectrum from normal structure to typical hypertrophy.